Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18175312 | 0.86 | CA1 (0.36) | CA1CA2 | |
| SCHEMBL10489150 | 0.82 | CA1 (0.40) | CA1CA2CA9 | |
| SCHEMBL9715497 | 0.79 | — | — | |
| SCHEMBL3213235 | 0.78 | CA1 (0.46) | CA1CA2CA9 | |
| SCHEMBL8714298 | 0.78 | — | — | |
| Ammonia Solution, Strong SCHEMBL28166358 | 0.76 | CA1 (0.43) | CA1CA2CA9 | |
| SCHEMBL6013335 | 0.74 | — | — | |
| SCHEMBL1795580 | 0.74 | — | — | |
| SCHEMBL6013332 | 0.74 | — | — | |
| SCHEMBL25630320 | 0.74 | CA1 (0.42) | CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100152261-A1 | NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2010-06-17 | — | — | US | disclosed |
| EP-1939183-A1 | NOVEL NITROGENATED HETEROCYCLIC COMPOUND | Mitsubishi Tanabe Pharma Corporation (JP) | 2008-07-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152261-A1 | NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | CHRM3, CHRM2, CHRM1 | CA1 867/4885CA2 507/4885CA9 2095/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.